IDH2 and oligodendroglioma: The TERT promoter is mutated very frequently in oligodendrogliomas and IDH-wild type GBM, and is only infrequently mutated in IDH-mutated, non-codeleted tumors (i.e., IDH-mutant astrocytomas) where it is seen in only 4% of cases.